Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001448703 | SCV001651802 | likely benign | Familial cancer of breast; Fanconi anemia complementation group J | 2024-01-09 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002429135 | SCV002743915 | likely benign | Hereditary cancer-predisposing syndrome | 2020-07-17 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Color Diagnostics, |
RCV002429135 | SCV004360303 | likely benign | Hereditary cancer-predisposing syndrome | 2022-08-15 | criteria provided, single submitter | clinical testing | |
Myriad Genetics, |
RCV004786628 | SCV005406733 | benign | Familial cancer of breast | 2024-08-12 | criteria provided, single submitter | clinical testing | This variant is considered benign. This variant is a silent/synonymous amino acid change and it is not expected to impact splicing. |